OTCPK:PLLW.F

Stock Analysis Report

Executive Summary

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally.

Snowflake

Fundamentals

Mediocre balance sheet and overvalued.

Risks

  • Polarean Imaging is not covered by any analysts.

Share Price & News

How has Polarean Imaging's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:PLLW.F

-0.9%

US Medical Equipment

1.3%

US Market


1 Year Return

n/a

OTCPK:PLLW.F

9.1%

US Medical Equipment

2.0%

US Market

No trading data on PLLW.F.

No trading data on PLLW.F.


Share holder returns

PLLW.FIndustryMarket
7 Day0%-0.9%1.3%
30 Day0%0.7%3.9%
90 Day0%4.4%3.4%
1 Yearn/a10.0%9.1%4.2%2.0%
3 Yearn/a70.7%65.5%47.2%37.6%
5 Yearn/a130.7%104.3%60.5%42.9%

Price Volatility Vs. Market

How volatile is Polarean Imaging's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Polarean Imaging undervalued based on future cash flows and its price relative to the stock market?

4.08x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Polarean Imaging to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Polarean Imaging to establish if it is available at substantial discount.


Price Based on Earnings

Polarean Imaging is loss making, we can't compare its value to the US Medical Equipment industry average.

Polarean Imaging is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Polarean Imaging, we can't assess if its growth is good value.


Price Based on Value of Assets

Polarean Imaging is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Polarean Imaging expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Polarean Imaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of PLLW.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Polarean Imaging's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Polarean Imaging performed over the past 5 years?

-44.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Polarean Imaging does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Polarean Imaging's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Polarean Imaging's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Polarean Imaging has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Polarean Imaging has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Polarean Imaging improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Polarean Imaging's financial position?


Financial Position Analysis

Polarean Imaging is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Polarean Imaging's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Polarean Imaging's level of debt (0.1%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Polarean Imaging's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1103.8x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Polarean Imaging has less than a year of cash runway based on current free cash flow.

Polarean Imaging has less than a year of cash runway if free cash flow continues to grow at historical rates of 53.2% each year.


Next Steps

Dividend

What is Polarean Imaging's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Polarean Imaging's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Polarean Imaging's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Polarean Imaging has not reported any payouts.

Unable to verify if Polarean Imaging's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Polarean Imaging has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Polarean Imaging's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average board tenure


CEO

Clairis Hullihen (66yo)

0yrs

Tenure

0

Mr. Clairis Richard Hullihen serves as the Chief Executive Officer of Polarean Imaging Plc and its Director since May 30, 2017. Mr. Hullihen has over 30 years in medical imaging experience. He began his ca ...


Board Age and Tenure

2.3yrs

Average Tenure

64yo

Average Age

The average tenure for the Polarean Imaging board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Chuck Osborne (53yo)

    Chief Financial Officer

    • Tenure: 0.3yrs
  • Ken West (62yo)

    COO & Director

    • Tenure: 2.3yrs
  • Bastiaan Driehuys (50yo)

    Founder

    • Tenure: 2.3yrs
  • Clairis Hullihen (66yo)

    CEO & Director

    • Tenure: 0yrs
  • Stephen Austin

    Company Secretary

    • Tenure: 1.4yrs

Board Members

  • Bob Bertoldi (65yo)

    Non-Executive Director

    • Tenure: 2.8yrs
  • Richard Cecil Morgan (74yo)

    Non-Executive Chairman

    • Tenure: 0yrs
  • Ken West (62yo)

    COO & Director

    • Tenure: 2.3yrs
  • Bastiaan Driehuys (50yo)

    Founder

    • Tenure: 2.3yrs
  • Jonathan Allis (56yo)

    Non-Executive Director

    • Tenure: 1.9yrs
  • Clairis Hullihen (66yo)

    CEO & Director

    • Tenure: 0yrs
  • Juergen Laucht (64yo)

    Non-Executive Director

    • Tenure: 2.3yrs

Company Information

Polarean Imaging plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Polarean Imaging plc
  • Ticker: PLLW.F
  • Exchange: OTCPK
  • Founded: 2016
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: UK£29.754m
  • Listing Market Cap: UK£36.156m
  • Shares outstanding: 114.44m
  • Website: https://www.polarean.com

Number of Employees


Location

  • Polarean Imaging plc
  • 2500 Meridian Parkway
  • Suite 175
  • Durham
  • North Carolina
  • 27713
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
POLXAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPMar 2018
PLLW.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDMar 2018

Biography

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company manufactures, sells, and services hyperpo ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/07 00:53
End of Day Share Price2019/05/09 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.